Prosecution Insights
Last updated: April 19, 2026

Salix Pharmaceuticals Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19299563 Solid Dispersion Forms of Rifaximin WEDDINGTON, KEVIN E 1629 Non-Final OA Aug 14, 2025
18241355 METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS) SCHMITT, MICHAEL J 1629 Non-Final OA Sep 01, 2023

Managing Salix Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month